Neil Josephson Zymeworks Inc. (ZYME) insider trading activity

Neil Josephson is Chief Medical Officer of Zymeworks Inc.. Currently has a direct ownership of 14,449 shares of ZYME, which is worth approximately $200,407. The most recent transaction as insider was on Nov 10, 2022, when has been sold 2,475 shares (Common Stock) at a price of $8.1 per share, resulting in proceeds of $20,047. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 14.4K

0% 3M change

0% 12M change

Total Value Held $200,407

Neil Josephson Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 10 2022	SELL Open market or private sale	$20,047 $8.1 p/Share	2,475 Reduced 14.62%	14,449 Common Stock
Nov 10 2022	BUY Exercise of conversion of derivative security	-	5,885 Added 25.8%	16,924 Common Stock
Jul 05 2022	BUY Grant, award, or other acquisition	$6,878 $4.51 p/Share	1,525 Added 12.14%	11,039 Common Shares
Mar 10 2022	BUY Exercise of conversion of derivative security	-	2,395 Added 20.11%	9,514 Common Shares
Jan 07 2022	BUY Open market or private purchase	$71,400 $14.28 p/Share	5,000 Added 41.26%	7,119 Common Shares
Jan 07 2022	BUY Grant, award, or other acquisition	$906 $13.94 p/Share	65 Added 2.98%	2,119 Common Shares
Jul 06 2021	BUY Grant, award, or other acquisition	$13,595 $29.49 p/Share	461 Added 18.33%	2,054 Common Shares

Also insider at

ZYME

Zymeworks Inc.

Chief Medical Officer

Neil Josephson

Chief Medical Officer

Vancouver, A1

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ZYME shares.

Notify only if

Value

Insider Trading

Get notified when an Zymeworks Inc. insider buys or sells ZYME shares.

Notify only if

Operation

Value

Type

News

Receive news related to Zymeworks Inc.

Track Activities on ZYME

Account